欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (4): 401-407.doi: 10.12092/j.issn.1009-2501.2021.04.007

• 临床药理学 • 上一篇    下一篇

OCTN2基因多态性影响结直肠癌奥沙利铂化疗敏感性

鲁琼1,朱海宏1,戚听听1,李国华1,滕欣琪1,屈强2,屈健1   

  1. 1中南大学湘雅二医院药剂科,中南大学临床药学研究所,长沙 410011,湖南;2中南大学湘雅医院药剂科,长沙 410078,湖南

  • 收稿日期:2020-11-17 修回日期:2021-03-10 出版日期:2021-04-26 发布日期:2021-05-11
  • 通讯作者: 屈健,男,博士,主管药师,研究方向:遗传药理学。 Tel: 0731-85292072 E-mail: qujianstanley@csu.edu.cn
  • 作者简介:鲁琼,女,副主任药师,研究方向:临床药学。 Tel: 18874788228 E-mail: christy_luq@csu.edu.cn
  • 基金资助:
    国家自然科学基金(82073944, 81603208);吴阶平医学基金(LCYX-Q001, 320.6750.19090-11)

OCTN2 gene polymorphisms affect the chemotherapeutic sensitivity of oxaliplatin in colorectal cancer

LU Qiong 1, ZHU Haihong 1, QI Tingting 1, LI Guohua 1, TENG Xinqi 1, QU Qiang 2, QU Jian 1   

  1. 1 Department of Pharmacy, the Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha 410011, Hunan, China; 2 Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
  • Received:2020-11-17 Revised:2021-03-10 Online:2021-04-26 Published:2021-05-11

摘要: 目的:研究OCTN2基因多态性是否影响OCTN2的表达和功能,以及结直肠癌细胞系SW480对奥沙利铂敏感性。方法:构建OCTN2基因4种突变(F17L、E317K、S467C和P478L)转染细胞系。Real-time RT-PCR及Western blot检测OCTN2 mRNA和蛋白水平的表达。HPLC检测细胞内奥沙利铂含量。MTS法检测细胞活性。结果:所有突变型OCTN2 mRNA和蛋白表达水平与野生型表达无统计学差异。E317K和S467C细胞系对奥沙利铂摄取(Vmax和Km)与野生型相比无差异(P>0.05),F17L的Vmax下降到66.4%,而Km值增加到120.3%,P478L的Vmax增加到132.6%,Km值降低到82.2%,与野生型相比有统计学差异(P<0.05)。所有过表达OCTN2细胞的IC50值显著降低。与SW480-OCTN2转染细胞系比较,没有转染的SW480细胞和F17L细胞系的IC50值分别升高175%和147%,而P478L细胞则下降到76.9%,有统计学差异(P<0.05)。E317K和S467C的IC50值无明显改变(P>0.05)。结论:OCTN2转运体基因F17L和P478L错义突变可以改变OCTN2对奥沙利铂的摄取,从而影响OCTN2稳定表达细胞系对奥沙利铂的敏感性。

关键词: 结直肠癌, 奥沙利铂, 化疗敏感性, OCTN2转运体

Abstract: AIM: To explore the effect of OCTN2 gene polymorphism on the expression and function of OCTN2, as well as the sensitivity of SW480 cells to oxaliplatin.  METHODS: Four mutations of OCTN2 (F17L, E317K, S467C and P478L) transfected cell lines were constructed. Real-time RT-PCR and Western blot were used to detect the levels of OCTN2 mRNA and protein. The content of oxaliplatin was detected by HPLC. MTS assay was used to detect cell viability. RESULTS: The expression level of all mutant OCTN2 mRNA and protein was not significantly different from that of wild-type OCTN2. Oxaliplatin uptake experiments showed that there was no significant difference in Vmax and Km values between E317K and S467C cells (P>0.05), the Vmax of F17L decreased to 66.4% and Km value increased to 120.3%; the Vmax of P478L increased to 132.6%, and the value of Km decreased to 82.2%, and there were significant differences (P<0.05). The cell activity test showed that the IC50 value of all overexpressed OCTN2 cells decreased significantly. Compared with SW480-OCTN2 transfected cell lines, IC50 values of SW480 cells without transfection and F17L cell lines were up to 175% and 147%, while P478L cells decreased to 76.9%, which had significant differences (P<0.05). The IC50 value of E317K and S467C did not change significantly (P>0.05). CONCLUSION: The OCTN2 transporter gene F17L and P478L mutations can alter the uptake of oxaliplatin by OCTN2 transporter, thereby affecting the sensitivity of OCTN2-stably expression cell line to oxaliplatin.

Key words: colorectal cancer, oxaliplatin, chemotherapeutic sensitivity, OCTN2 transporter

中图分类号: